A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov
SY Wang, WQ Liu, YQ Li, JX Li… - Expert Review of Vaccines, 2023 - Taylor & Francis
Introduction The global spread of COVID-19 has prompted the development of vaccines. A
recombinant adenovirus type-5 vectored COVID-19 vaccine (Ad5-nCoV) developed by …
recombinant adenovirus type-5 vectored COVID-19 vaccine (Ad5-nCoV) developed by …
Influenza B: prospects for the development of cross-protective vaccines
LM Tsybalova, LA Stepanova, ES Ramsay, AV Vasin - Viruses, 2022 - mdpi.com
In this review, we analyze the epidemiological and ecological features of influenza B, one of
the most common and severe respiratory infections. The review presents various strategies …
the most common and severe respiratory infections. The review presents various strategies …
Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination
JA Misplon, CY Lo, TA Crabbs, GE Price… - Journal of …, 2023 - Am Soc Microbiol
New approaches to vaccination are needed for protection against rapidly evolving viruses
because emerging variant strains often evade neutralizing antibodies. Alternative strategies …
because emerging variant strains often evade neutralizing antibodies. Alternative strategies …
The protective effect of intranasal immunization with influenza virus recombinant adenovirus vaccine on mucosal and systemic immune response
YB Lian, MJ Hu, TK Guo, YL Yang, RR Zhang… - International …, 2024 - Elsevier
Influenza virus is a kind of virus that poses several hazards of animal and human health.
Therefore, it is important to develop an effective vaccine to prevent influenza. To this end we …
Therefore, it is important to develop an effective vaccine to prevent influenza. To this end we …
Self-assembled multiepitope nanovaccine based on NoV P particles induces effective and lasting protection against H3N2 influenza virus
J Nie, Q Wang, S Jin, X Yao, L Xu, Y Chang, F Ding… - Nano research, 2023 - Springer
Current seasonal influenza vaccines confer only limited coverage of virus strains due to the
frequent genetic and antigenic variability of influenza virus (IV). Epitope vaccines that …
frequent genetic and antigenic variability of influenza virus (IV). Epitope vaccines that …
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages
C Gravel, A Muralidharan, A Duran, A Zetner, A Pfeifle… - Iscience, 2021 - cell.com
A quarter of all seasonal influenza cases are caused by type B influenza virus (IBV) that also
dominates periodically. Here, we investigated a recombinant adenovirus vaccine carrying a …
dominates periodically. Here, we investigated a recombinant adenovirus vaccine carrying a …
H5Nx 禽流感病毒交叉反应性CD4+ T 细胞表位预测
谢爽, 陈瑶, 黄俊琼 - 生物技术通报, 2024 - biotech.aiijournal.com
[目的] 评估预先存在的H5Nx 交叉反应性免疫记忆, 为人类H5 禽流感病毒的防治和广谱疫苗的
研发提供理论数据.[方法] 利用生物信息学方法筛选人源H5Nx 禽流感病毒与季节性流感病毒的 …
研发提供理论数据.[方法] 利用生物信息学方法筛选人源H5Nx 禽流感病毒与季节性流感病毒的 …
Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines
LA Stepanova, MA Shuklina, KA Vasiliev, AA Kovaleva… - Vaccines, 2022 - mdpi.com
Efficient control of influenza A infection can potentially be achieved through the development
of broad-spectrum vaccines. Recombinant proteins incorporating conserved influenza A …
of broad-spectrum vaccines. Recombinant proteins incorporating conserved influenza A …
Prediction of H5Nx Avian Influenza Virus Cross-reactivity CD4+ T-cell Epitopes
S XIE, Y CHEN, J HUANG - Biotechnology Bulletin, 2024 - biotech.aiijournal.com
[Objective] To evaluate preexisting H5Nx cross-reactivity immune memory and to provide
theoretical data for the prevention and treatment of human H5 avian influenza viruses and …
theoretical data for the prevention and treatment of human H5 avian influenza viruses and …
[PDF][PDF] Conventional and Advanced Approaches in Veterinary Vaccines
Veterinary vaccination is one of the main effective measures to reduce and eradicate
impairment prompted by infectious diseases in animals and humans. Various vaccines are …
impairment prompted by infectious diseases in animals and humans. Various vaccines are …